Literature DB >> 33178527

X-Linked Hypophosphatemic Rickets Manifesting as Sclerotic Bone Disease and Enthesopathy.

Hiya Boro1, Shailendra Singh Naik2, Charandeep Singh3, Saurav Khatiwada3, Rajesh Khadgawat1.   

Abstract

X-linked hypophosphatemic (XLH) rickets is a genetic disease caused due to the inactivation of the PHEX gene (phosphate regulating gene with homology to endopeptidase on the X chromosome). The usual presentation is with rickets and osteomalacia, and dental abscesses leading to premature loss of teeth. However, enthesopathy and sclerotic bone disease in XLH have also been reported in a few case reports. In this report, we describe the case of a 23-year-old female patient who presented to us with severe bone deformities, proximal myopathy, truncal weakness, and recent onset of pain and stiffness around the joints. She was diagnosed with XLH and was found to have severe enthesopathy along with heterotopic ossification.
Copyright © 2020, Boro et al.

Entities:  

Keywords:  dental abscess; enthesopathy; hypophosphatemia; osteosclerosis; rickets

Year:  2020        PMID: 33178527      PMCID: PMC7652373          DOI: 10.7759/cureus.10874

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  10 in total

1.  Phenotype presentation of hypophosphatemic rickets in adults.

Authors:  Signe S Beck-Nielsen; Klaus Brusgaard; Lars M Rasmussen; Kim Brixen; Bendt Brock-Jacobsen; Mette R Poulsen; Peter Vestergaard; Stuart H Ralston; Omar M E Albagha; Sven Poulsen; Dorte Haubek; Hans Gjørup; Hanne Hintze; Mette G Andersen; Lene Heickendorff; Jacob Hjelmborg; Jeppe Gram
Journal:  Calcif Tissue Int       Date:  2010-06-04       Impact factor: 4.333

2.  Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms.

Authors:  Hélène Che; Christian Roux; Adrien Etcheto; Anya Rothenbuhler; Peter Kamenicky; Agnès Linglart; Karine Briot
Journal:  Eur J Endocrinol       Date:  2016-03       Impact factor: 6.664

3.  Familial hypophosphatemic vitamin D-resistant rickets: dental findings and histologic study of teeth.

Authors:  T Murayama; R Iwatsubo; S Akiyama; A Amano; I Morisaki
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2000-09

4.  Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice.

Authors:  Guoying Liang; Lee D Katz; Karl L Insogna; Thomas O Carpenter; Carolyn M Macica
Journal:  Calcif Tissue Int       Date:  2009-07-17       Impact factor: 4.333

5.  Dental abnormalities and oral health in patients with Hypophosphatemic rickets.

Authors:  Melissa Almeida Souza; Luiz Alberto Valente Soares Junior; Marcela Alves Dos Santos; Maria Helena Vaisbich
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

6.  Oral and dental manifestations of vitamin D-dependent rickets type I: report of a pediatric case.

Authors:  Marlene Zambrano; Nikolaos G Nikitakis; M Carmen Sanchez-Quevedo; John J Sauk; Heddie Sedano; Helen Rivera
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2003-06

7.  Calcification of entheses associated with X-linked hypophosphatemic osteomalacia.

Authors:  R P Polisson; S Martinez; M Khoury; R M Harrell; K W Lyles; N Friedman; J M Harrelson; E Reisner; M K Drezner
Journal:  N Engl J Med       Date:  1985-07-04       Impact factor: 91.245

Review 8.  Hypophosphatemia: the common denominator of all rickets.

Authors:  Dov Tiosano; Ze'ev Hochberg
Journal:  J Bone Miner Metab       Date:  2009-06-06       Impact factor: 2.626

9.  Dental management of patients with X-linked hypophosphatemia.

Authors:  Bin-Na Lee; Hye-Yoon Jung; Hoon-Sang Chang; Yun-Chan Hwang; Won-Mann Oh
Journal:  Restor Dent Endod       Date:  2017-01-06

10.  Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.

Authors:  Dieter Haffner; Francesco Emma; Deborah M Eastwood; Martin Biosse Duplan; Justine Bacchetta; Dirk Schnabel; Philippe Wicart; Detlef Bockenhauer; Fernando Santos; Elena Levtchenko; Pol Harvengt; Martha Kirchhoff; Federico Di Rocco; Catherine Chaussain; Maria Louisa Brandi; Lars Savendahl; Karine Briot; Peter Kamenicky; Lars Rejnmark; Agnès Linglart
Journal:  Nat Rev Nephrol       Date:  2019-07       Impact factor: 28.314

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.